Diminution of 37-kDa laminin binding protein expression reduces tumour formation of murine lung cancer cells by Satoh, K et al.
It is well-known that the interaction between laminin, a major
glycoprotein component of the basement membrane, and laminin
receptor, a member of the integrin family, on the cancer cell
surface is one of the crucial factors during tumour growth, inva-
sion and metastasis (Hunt, 1989). Besides the integrin family, the
laminin binding protein (37LBP/p40), the molecular size of which
is 37–40kDa, has been described. 37LBP/p40 has been proven to
be a precursor protein of the non-integrin 67-kDa laminin receptor
(67LR) (Wewer et al, 1987; Sobel, 1993) as demonstrated by
pulse-chase and transfection experiments (Castronovo et al.,
1991a, 1991b).
Expression of 37LBP/p40 is reported to be up-regulated in
human colon cancer (Castronovo et al, 1992; Kim et al, 1998) and
breast cancer (Shi et al, 1993; Menard et al, 1994). In previous
reports including ours, increased expression of 37LBP/p40 has
also been demonstrated in human lung cancer, especially in the
highly aggressive cell types such as small-cell and alveolar-cell
cancer (Satoh et al, 1992; Ferrarini et al, 1994; Pellegrini et al,
1994).
On the other hand, 37LBP/p40 appears to be a multifunctional
protein involved in the translational machinery and identified as
p40 ribosome-associated protein (Auth and Brawerman, 1992;
Davis et al, 1992; Demianova et al, 1996). Thus, 37LBP/p40 is
still controversial, and detailed functions of 37LBP/p40 are not yet
fully understood (Mercurio and Shaw, 1991; Yang et al, 1992;
Demianova et al, 1996).
Most recently, the gene for 37LBP/p40 has been cloned (Jackets
et al, 1996). Interestingly, the active gene is localized on chromo-
some 3 in the locus 3p21.3, which is a hot spot for genetic alter-
ations in several cancers, particularly in small-cell lung cancer
(Karp and Broder, 1995). In this context, it is very alluring to
elucidate the role played by 37LBP/p40 in lung cancer.
In the present study, we established a murine lung cancer cell
line, with the 37LBP/p40 production being extremely inhibited
by the introduction of antisense RNA from reverse-orientated-
37LBP/p40 cDNA. As a result, the population doubling time of
the transfectant with 37LBP/p40 antisense RNA was prolonged as
compared with the parental cells without transfection in vitro. In
addition, the primary tumour growth of transplanted cells with
antisense 37LBP/p40 RNA was retarded in syngenic mice. These
observations suggest a promotive role of 37LBP/p40 in the prolif-
eration and tumorigenicity of lung cancer cells.
MATERIALS AND METHODS
Cells and vector
Murine lung cancer cell line P29 (Nakanishi et al, 1992) derived
from Lewis lung carcinoma (3LL) was a generous gift of Dr M
Okayama (Kyoto, Japan). Retroviral vector N2 and its packaging
cell line Y2 (Eglitis et al, 1985) were provided by Dr R Mulligan
(MIT, Cambridge, MA, USA).
Diminution of 37-kDa laminin binding protein expression
reduces tumour formation of murine lung cancer cells
K Satoh1, K Narumi1, T Abe1, T Sakai1, T Kikuchi1, M Tanaka1, T Shimo-Oka3, M Uchida3, F Tezuka2, M Isemura4
and T Nukiwa1
Departments of 1Respiratory Oncology and Molecular Medicine, and 2Pathology, Institute of Development, Aging and Cancer, Tohoku University,
4-1 Seiryo-Machi, Aoba-ku, Sendai 980-8575, Japan; 3Life Science Center, Iwaki Glass Co., Ltd, Funabashi 273-0044, Japan; 4Department of Biochemistry,
School of Food and Nutritional Sciences, University of Shizuoka, Shizuoka 422-0000, Japan
SummaryExpression of the 37-kDa laminin binding protein (37LBP/p40), a precursor of the 67-kDa laminin receptor, is well-correlated with
the biological aggressiveness of cancer cells. To elucidate the direct role played by 37LBP/p40 in cancer cells, a murine lung cancer cell line
T11, the 37LBP/p40 expression of which was remarkably diminished, was established by the introduction of the antisense 37LBP/p40-RNA
using a retroviral vector. As a result, the population doubling time of T11 was prolonged (60h) compared with that of P29, the non-transfected
parental cell line (42h), and TN2, a transfectant with vehicle only (40h). In-vitro studies also showed that T11 cells adhered to immobilized
laminin less firmly than P29 cells did. When 5 ´105 cells were subcutaneously inoculated into syngenic mice, the mean survival time of T11-
recipients (77.0 ±14.8 days) was also significantly prolonged compared with that for P29 (34.8 ±5.5 days) and TN2 (36.7 ±6.1 days)
recipients (P < 0.001). The electron-microscopic view of the tumour tissue revealed that T11 cells were loosely apposed and their intercellular
space was markedly widened. Some of the T11 cells sporadically degenerated with the infiltration of lymphocytes and neutrophils. These
results suggest that the suppressed expression of 37LBP/p40 reduces the capability of lung cancer cell proliferation in vitro and tumour
formation in vivo.
Keywords: laminin receptor; 37LBP/p40; mouse; lung cancer; antisense RNA; tumorigenicity
1115
British Journal of Cancer(1999) 80(8), 1115–1122
©1999 Cancer Research Campaign
Article no. bjoc.1999.0474
Received 28 October 1996
Revised 5 January 1999
Accepted 6 January 1999
Correspondence to:  K SatohDNA and plasmid construction
Full-length murine 37LBP/p40 cDNA (pKN57) was obtained
by reverse transcription polymerase chain reaction (RT-PCR)
(Robinson and Simon, 1991) of the total RNA of the P29 cells.
Two oligonucleotide primers for RT-PCR (LNR-14:
5´ATAGCTCGAG-CTTGATTCCCATCGTAACTT3´; LNR-15:
5´ACCACTCGAGTGG-TGGCTCCAACCCACTCA3´) were
synthesized according to the sequence of murine 37LBP/p40
cDNA (Rao et al, 1989) with the XhoI site at each 5´ end. The
nucleotide sequence of the cDNA insert was confirmed by the
dideoxy chain termination method. The retroviral vector used for
the introduction of the antisense RNA was constructed from N2
as shown in Figure 1A. An insert of the pKN57 (940-bp) was
subcloned in reverse direction in the XhoI site of N2 by a standard
technique and was designated pN2PBL.
Transfection and infection
Psi2 cells were grown in non-selective Eagle’s modified essential
medium (EMEM) containing 2 mM glutamine and 10% calf serum
at 37°C under 10% carbon dioxide. Plasmid pN2PBL was trans-
fected into Y2 cells by the calcium phosphate method (Miller et al,
1985). The cells were grown in selective medium containing G418
(neomycin sulphate) at a concentration of 0.3 g l–1 to select
neomycin-resistant clones. The selected clones (Y 2PBL) pack-
aged the transcripts from the integrated pN2PBL into ecotropic
retroviral particles. P29 cells were infected by the culture super-
nate of the Y 2PBL cells (titre > 105 cfu ml–1) as described by
Miller et al. (1985) and cultured in selective medium (EMEM,
2m M glutamine, 10% fetal calf serum with 0.5 g l–1 G418) at 37°C
under 5% carbon dioxide. Fifty neomycin-resistant P29 clones,
referred to as Transfectant 1–50 (T1–T50), were isolated using a
cloning ring and were used for the following experiments. Some
P29 cells were infected with N2 vehicle only and cloned as a
negative control polyclonal cell line referred to as TN2. For the
determination of the population doubling time, cells were plated
in a 35 mm-diameter dish at an initial density of 103 cells. The
absence of mycoplasma infection in each cell line was confirmed
by a Gene-Probe mycoplasma detection kit (Chugai, Tokyo,
Japan).
DNA and RNA analysis
To confirm the integration of pN2PBL into the genome of trans-
fectant cells, Southern analysis was carried out using the genomic
DNA of the transfectant cells digested with restriction enzyme
XbaI, for which the recognition site was located within both LTR
sequences. The blotted nylon membrane Nytran (Schleicher and
Schuell, Keene, NH, USA) was hybridized with a radiolabelled
37LBP/p40 cDNA probe (pKN57). Endogenous gene expression
of 37LBP/p40 was evaluated using total RNA of the cells by
Northern blot analysis with the cDNA probe described above.
Immunostaining
Cells (1 ´ 105) were seeded onto a LAB-TEK chamber (Nunc,
Roskilde, Denmark) and cultured for 24 h. After washing and
fixing with cold acetone, the LAB-TEK chamber was immuno-
stained with a polyclonal antibody P1 that was raised against the
C-terminal end of the human 37LBP/p40 polypeptide (PTED-
WSAQPATEDWSAAPTA in one-letter amino acid symbols),
which has been described previously (Rao et al, 1989).
Western blot analysis
Total cellular proteins were extracted by a method using a solution
containing detergents and various kinds of protease inhibitor. The
cell lysates were clarified by centrifugation and electrophoresed
on 7.5% sodium dodecyl sulphate (SDS) polyacrylamide gel
(Laemmli, 1970), followed by immunoelectroblotting onto a
Nytran. Immunoblotting was carried out with the polyclonal anti-
body described above. For normalization of 37LBP/p40 protein
expression, the same filter was blotted with anti-b-actin antibody
(Santa Cruz Biotechnology, CA, USA).
FACScan analysis
Cells were harvested and analysed by flow cytometry according to
the method of Landowski et al (1995). Briefly, unpermeabilized
cells were incubated with the murine monoclonal anti-human
37LBP/p40 antibody M1 (Iwaki-Grass, Funabashi, Japan), which
was converted from a polyclonal antibody P1, or with PBS for
60 min on ice. After pelleting the cells and resuspending them
in PBS, the secondary antibody, fluorescein isothiocyanate
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Figure 1 Construction of vector and transfection into P29 cells.
(A) Construction of the antisense RNA expression vector N2PBL.
Complementary DNA for 37LBP/p40 was obtained from P29 cells by the
method of RT-PCR and was subcloned into the XhoI site of retroviral vector
N2 (Eglitis et al., 1985) in opposite orientation as designated PBL in contrast
to 37LBP/p40. Sense RNA of the neomycin-resistant gene and antisense
RNA of the 37LBP/p40 gene were expressed under the direction of the 5¢-
LTR promoter. y indicates a packaging signal. (B) Southern hybridization of
the genomic DNA digested with XbaI. There is no XbaI site in the plasmid
construction except for two in the LTR sequence. After transfer of digested
genomic DNA, the nylon membrane filter was hybridized with radiolabelled
37LBP/p40 cDNA probe. The expected 4.3-kb bands containing genes of
neomycin-resistance and 37LBP/p40 cDNA were shown in T11 (lane 1) and
T15 (lane 2) cells. Note that no positive band was found in TN2 (transfectant
with N2 vector only; lane 4) and in P29 (parental cell without transfection;
lane 5). The plasmid pN2PBL was shown as a positive control (lane 3)Laminin receptors in murine lung cancer 1117
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Figure 2 Inhibition of endogenous 37LBP/p40 expression in transfectant T11 by antisense RNA. (A) Northern blot analysis of 37LBP/p40. Fifteen micrograms
of total RNA per lane was electrophoresed and transferred onto nylon membrane. Hybridization was performed with radiolabelled 37LBP/p40 cDNA probe. Note
that endogenous gene product (1.4 kb) was remarkably reduced in T11 (lane 2) and T15 (lane 3) cells compared with controls P29 (lane 1). Bands (4.4-kb) seen
in both lane 2 and lane 3 were regarded as exogenous antisense transcripts for 37LBP/p40. An antisense 37LBP/p40 transcript of T11 was also indicated by
Northern hybridization with sense oligonucleotide probe (lane 4). The same membrane was hybridized with b-actin probe as a control (lanes 1–3). (B) Western
blot analysis of 37LBP/p40. Whole extract of 1 ´ 105 cells was electrophoresed on 7.5% SDS-polyacrylamide gel. Note that the synthesis of the 37LBP/p40 was
suppressed in both T11 and T15 cells (lanes 2 and 3 respectively) compared with P29 (lane 1). The same membrane was immunoblotted with anti-b-actin
antibody for normalization of 37LBP/p40 protein expression. (C) FACScan analysis of the surface expression of the 37LBP/p40 protein. Cells were treated with
anti-37LBP/p40 antibody and stained with FITC-conjugated goat anti-murine secondary antibody. Endogenous expression of 37LBP/p40 was decreased on the
cell surface of antisense-transfectant T11 (lower panel) compared with that of parental cell P29 (upper panel). Ordinate and abscissa indicate the cell number
and the fluorescence intensity respectively. (D) Difference in morphology between P29 and T11 cells. Cells were photographed 12 h after plating in plastic
culture dish. T11 cells (lower panel) appear larger than parental P29 cells with rich cytoplasm (upper panel). Original magnification is ´ 100(FITC)-labelled goat anti-murine immunoglobulin (Sigma), was
added and allowed to react for 60 min on ice. Analysis was
performed on a Becton Dickinson FACScan (Franklin Lakes, NJ,
USA). The transfected cells were assayed as soon as the popula-
tion had stabilized after G418 selection.
Assays for attachment and detachment to immobilized
laminin
Cell adherence to laminin was evaluated by the method of
Nakanishi et al (1992). In attachment assay, cells (2.5 ´ 105 per
well) were plated onto a 24-well laminin-coating dish (Gibco
BRL, Rockville, MD, USA) and allowed to adhere. At various
time points, unattached cells were carefully removed by washings
with PBS, and the remaining adherent cells were recovered by
0.01% (w/v) trypsin to be counted. Cell attachment was shown as
the ratio of remaining cell count/initial cell count (2.5 ´ 105). In
detachment assay, cells (2.5 ´ 105 per well) were plated onto a
laminin-coating dish and incubated for 20 h. The cell layer was
washed twice with PBS and then rotated on an orbital shaker
(Marisol, Tokyo, Japan) in PBS containing 0.002% (w/v) trypsin
at 100 rpm for the indicated times. The percentage of detached
cells was calculated with the cell count at 0 min.
Inoculation of the cells
Cells (5 ´ 105) were subcutaneously injected into the left shoulders
of syngenic mice C57BL/6 (ten animals per group). Growth of the
primary tumour was monitored every 5 days by caliper measure-
ment, and mice were observed until they died from tumour
development. To indicate the expression of the 37LBP/p40 protein
in the transplanted tumour, a Western blot of the T11 tumour was
also carried out. Metastases to the lung, liver and axillar lymph
node were macroscopically observed in T11 and P29
recipients (five mice per group) on day 35.
Electron-microscopical analysis
Primary subcutaneous tumour tissues were fixed in 2.5%
glutaraldehyde, 2.0% paraformaldehyde, 0.1 M phosphate buffer
(pH 7.3) for 2 h, post-fixed in 1% osmium tetroxide, and
embedded in Epon 812 (Taab, Berkshire, UK). Ultra-thin sections
were stained with uranyl acetate followed by lead citrate and
examined by an electron microscope (Hitachi, H-7100).
Statistical analyses
The significance of differences in the mean survival time of mice
transplanted with three cell lines was assessed with ANOVA.
RESULTS
Construct of antisense 37LBP/p40 RNA transfectant
Fifty neomycin-resistant clones were obtained by G418 selection.
Two of them (T11 and T15) transcribed antisense RNA from the
pN2PBL transferred by retroviral vector. Southern blot analysis
indicated that the pN2PBL insert was integrated into the genomes
of T11 and T15 cells (Figure 1B). No insert DNA was demon-
strated in the genomes of P29 and TN2 cells. Integration of
pN2PBL was also substantiated by RT-PCR analysis using a
specific primer for the NeoR gene (Beck et al, 1982) and LNR-14
primer described above. Northern and Western blot analyses
showed that endogenous expressions of 37LBP/p40 were remark-
ably suppressed in both antisense RNA-transfectant T11 and T15
(Figure 2 A,B). We thereafter chose T11 for experiments because
suppression of the endogenous 37LBP/p40 expression was greater
in T11 than in T15.
Phenotype of antisense RNA transfectant T11
To estimate the expression of 37LBP/p40 protein on the cell
surface, a FACScan analysis was performed using parental cells
P29 and antisense-transfectant T11 (Figure 2C). As a result, the
expression of the 37LBP/p40 protein of T11 decreased compared
with that of P29, supporting the results of the Northern and
Western analyses. The immunoreactivity of the T11 cells was far
lower than that of the P29 cells, consistent with the Western blot
analysis of whole cell extract as shown in Figure 2B (data not
shown). Morphologic characteristics of the cell lines are shown in
Figure 2D. Parental P29 cells were relatively small and round
(upper panel), while T11 cells were larger than the P29 cells with
rich cytoplasm (lower panel).
T11 showed a prolonged doubling time. From the logarithmic
phase of the cell growth curve, the population doubling times of
P29 (parental cells), TN2 (vehicle-transfectant), and T11 were
calculated to be 42 h, 40 h, and 60 h respectively. This suggests
that the suppressed expression of 37LBP/p40 reduced the prolifer-
ation rate of the T11 cells. The differences in doubling time were
also documented even in the medium containing an excess amount
of EHS laminin (10 ng ml–1), indicating that the proliferation rate
of each cell line was not significantly changed by exogenous
laminin.
Cell adherence to immobilized laminin
In vitro analyses showed that the initial rate and extent of attach-
ment of T11 cells to immobilized laminin were lower than those of
P29 cells (Figure 3A). To demonstrate the difference in the poten-
tial for laminin attachment, resistance to detachment was also esti-
mated by trypsin-treatment. As shown in Figure 3B, T11 cells (n)
were less resistant to trypsinization than P29 cells (•) in the
laminin-coating dish.
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Figure 3 Cell attachment and detachment to immobilized laminin. Results
are presented as the mean value of triplicate. Standard deviations were less
than 10% of the mean. (A) Attachment assay. Note that both the initial rate
and the extent of attachment of T11 (n) were lower than those of P29 (•).
(B) Detachment assay by trypsin treatment. T11 (n) was less resistant to
trypsinization than P29 (•) on the laminin-coating dishTable 1 Autopsy of recipient mice on day 35 after tumour inoculation
Tumour cell Body weight Tumour Metastasis
(g) Diametera (cm) Weighta (g) Lunga Livera Lymph node
P29 (n = 5) 48.40 ± 1.67 3.44 ± 0.44 14.54 ± 4.85 2.80 ± 1.92 2.40 ± 1.14 0.20 ± 0.45
T11 (n = 5) 43.88 ± 4.94 1.0 ± 0.7 0.97 ± 0.72 0 0 0
aP < 0.001 
Subcutaneous inoculation into syngenic mice
The tumorigenicity of each cell line in vivo was investigated with
respect to the mortality due to tumour growth in recipient mice.
Inoculated T11 tumour grew more slowly than P29 and TN2
tumours with respect to tumour diameter (Figure 4A). There was a
remarkable difference in the survival curves between syngenic
mice inoculated with T11 cells and those inoculated with P29 cells
and TN2 cells (Figure 4B). Ten recipients of P29 and TN2 were all
dead within 40 days, indicating no significant difference in tumori-
genicity between these two groups. In contrast, tumour growth in
recipients of T11 was far slower, and some mice survived over 120
days. The expression of the 37-kDa protein was extremely reduced
in T11 tumours generated in syngenic mice as well as in T11 cells
(Figure 4B, inset). When animals (five mice each) were sacrificed
35 days after the subcutaneous inoculation of the cells, macro-
scopic metastases were observed in the lung, liver and the axillar
lymph nodes of P29-recipients. In contrast, no metastasis was seen
in T11-recipients (Table 1).
Histological analysis of tumour tissue
Electron-microscopically, P29 formed groups of epithelial
neoplastic cells (Figure 5A). They were polygonal and closely
apposed and had small intercellular junctions. They had a rela-
tively small amount of cytoplasm, and the main components of the
cytoplasm were free ribosomes, mitochondria and rough endo-
plasmic reticulum. Nuclei were large, irregularly shaped, and had
large nucleoli. Electron-microscopical findings for TN2 cells
infected with vehicle only were generally similar to those for P29
cells (data not shown). T11 cells were, in contrast, loosely
apposed, and their intercellular space was markedly widened
(Figure 5B). The intercellular junctions were few, and the develop-
ment of microvilli was prominent. Some of the T11 cells sporadi-
cally degenerated, and the infiltration of lymphocytes and
neutrophils was observed (Figure 5C).
DISCUSSION
The aim of the present study was to try to diminish the expression
of 37LBP/p40 protein expression in cancer cells in order to better
understand its role in tumorigenicity. As a result, we established a
cell line T11 derived from murine Lewis lung carcinoma with a
depletion of 37LBP/p40 by antisense RNA, and demonstrated a
phenotype of reduced tumorigenicity. The clone T11 differs from
the parental cell line P29 in the following points. First, T11 cells
are less closely apposed, their intercellular spaces are markedly
widened, and their cell borders are irregular with a prominent
development of microvilli, while P29 cells are polygonal and
tightly apposed with numerous small intercellular junctions.
Secondly, the cell proliferation rate of T11 is lower than that of
P29 in vitro. Finally, the tumorigenicity of T11 is far diminished
compared to that of P29 when inoculated into syngenic mice.
The relationship between the reduced 37LBP/p40 expression
and the morphological and tumorigenic changes of T11 cells has
not yet been fully elucidated, but we suggest it to be as follows.
Laminin receptors in murine lung cancer 1119
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Figure 4 In-vivo effect of antisense 37LBP/p40 RNA in syngenic mice. Cells (5 ´ 105) were subcutaneously injected into the left shoulder of a male C57BL/6
syngenic mouse. (A) Take of tumour in recipient mouse was estimated in regard to the tumour diameter. The T11 tumour (closed bar) grew more slowly than
both the P29 (dotted bar) and TN2 (open bar) tumours. (B) The survival curve (Kaplan–Meier’s plot) was obtained using ten mice per group. The mean survival
time of P29, TN2, and T11 were calculated at 34.8 ± 5.5 days, 36.7 ± 6.1 days, and 77.0 ± 14.8 days respectively. The tumorigenicity with regard to the
mortality of T11 was significantly reduced compared with those of P29 and TN2 (P < 0.001). Inset: Western blot of T11 transplanted tumour indicates an
extremely reduced expression of the 37-kDa protein as well as that of T11 cells1. The formation of the tumour matrix and/or complete cell–cell
contact might be affected due to defective laminin binding
ability of the T11 cells. A loose structure formation of the
extracellular matrix was observed in our preliminary study
in T11 tumour tissue by immunohistochemistry using
anti-laminin and anti-collagen IV antibodies. In addition,
a widened intercellular space and a poorly developing
desmosome were demonstrated by electron microscopy, as
shown in Figure 5.
2. Suppressed angiogenicity of the T11 tumour might be a likely
cause of the diminished tumorigenicity. Vacca et al (1993)
have indicated that a more frequent interaction between
melanoma cells and their microvasculature via laminin is
absolutely necessary during tumour progression. Gasparini
et al (1995) have also reported a relationship between the
expression of 67LR and the density of the intratumoural
microvessels, and have shown that measurement of 67LR
expression might provide useful prognostic information in
human breast cancer.
3. Apoptosis might be induced in the T11 cells by means of the
introduction of 37LBP/p40 antisense RNA. The amino acid
sequences deduced from 37LBP/p40-cDNA of several species
show a dramatically high degree of conservation during
evolution (Mercurio and Shaw, 1991). This fact reinforces the
idea that the 37LBP/p40 protein might play a fundamental role
in cell metabolism. As a consequence, it can be postulated that
the 37LBP/p40 protein might play a double function in cells:
one as a monomer in the translation machinery and, when
modified or associated with another protein, as a laminin
binding protein, a receptor for the Sindobis virus (Wang et al,
1992), a receptor for the prion protein (Rieger et al, 1997), or a
positional marker protein in the embryonic retina (McCaffery
et al, 1990) (N Clausse and V Castronovo, personal
communication). Considering these possibilities, it might
well be that the diminished level of 37LBP/p40 protein in
cells might result in an increase in cell death because the
37LBP/p40 protein would not be present anymore to play its
potentially fundamental role as a ribosomal associated protein
in an antisense-transfectant T11. In order to assess this
possibility, the apoptosis level of the T11 clone in culture
should be measured.
4. A reduction in 37LBP/p40 expression might be involved in
tumour suppression by the host immune system. A large
number of mononuclear cells (lymphocytes and monocytes)
infiltrated into the T11 tumour tissue in contrast to P29 and
TN2 tumour tissues that contained few mononuclear cells. It is
postulated that reduced angiogenesis in the T11 tumour causes
tumour autolysis, apoptosis and the resulting accumulation of
mononuclear cells in the tissue. On the other hand, strong
immune response to DNA by recognition of unmethylated
CpG motifs within exogenous oligonucleotide has recently
been pointed out (Krieg et al, 1989, 1995). Whether antisense
RNA generated from integrated DNA in genome of
mammalian cells also triggers host immune system is not
clear.
5. It should also be considered that an intracellular marker gene,
e.g. NeoR, may negatively influence the survival of trans-
planted cells in vivo (Tapscott et al, 1994). However, TN2 that
had been infected only by vehicle with selective marker
indicated no significant alterations in phenotype compared
with P29.
Antisense strategies have been used previously to diminish
or abolish the expression of extracellular matrix receptor other
than 37LBP/p40. For example, antisense RNA of a2b1, a
collagen/laminin receptor, interferes the organization of breast
cancer cells in three-dimensional collagen gels (Keely et al, 1995),
and antisense oligonucleotides of a1b1, another collagen/laminin
1120 K Satoh et al
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Figure 5 Electron micrographs of the primary tumour of P29 and T11 cells.
(A) P29 cells are polygonal, tightly apposed, and have small intercellular
junctions (´ 4000). The bar indicates 20 mm. (B) T11 cells show markedly
widened intercellular spaces and a prominent development of microvilli
(´ 10 000). The bar indicates 40 mm. (C) Degenerated cells appear
sporadically in the T11 tumour with infiltrations of lymphocytes and
neutrophils (´ 2000). The bar indicates 10 mmreceptor, prevents fibroblasts from matrix remodelling seen during
morphogenesis and wound healing (Carver et al, 1995).
Besides antisense strategies, the results using peptides to ECM
receptors have been reported. It has been known that peptides
containing the b1 integrin recognition sequence, RGD, can inhibit
experimental or spontaneous metastasis (Saiki et al, 1989;
Pasqualini et al, 1997). As well as integrin, 37LBP/p40 plays a role
in the attachment and migration of tumour cells in vitro to laminin-
coated surfaces and in vivo during lung colonization by intra-
venously injected tumour cells (Wewer et al, 1987). Thus
37LBP/p40 has potentially provided the basis for new anticancer
therapeutic strategies. Iwamoto (1987) demonstrated that synthetic
YIGSR peptide derived from the sequence of the laminin B1 chain
and reported to be a binding site for 37LBP/p40 (Graf et al, 1987),
inhibited experimental metastasis of B16 melanoma. Recently, it
has been shown that a multimeric form of YIGSR sequence
reduced angiogenesis, tumour growth and experimental metastasis
of HT1080 more effectively than a monomeric form did (Iwamoto
et al, 1996). On the other hand, Castronovo et al (1991c) have
demonstrated that 37LBP/p40 on the cell surface was reduced by
synthetic peptide G, a high-affinity laminin-binding site in the
37LBP/p40, and that adhesion of melanoma cells to the vascular
endothelium was inhibited specifically and drastically. They also
indicated that a peptide G sequence was necessary to stabilize the
laminin binding of cancer cells (Magnifico et al, 1996).
The present study demonstrates that the increase in the survival
of T11-inoculated mice is caused cooperatively by (a) delayed
time in tumour appearance, (b) reduced growth rate of tumours and
(c) no metastasis formation. These results suggest that the suppres-
sion of 37LBP/p40 expression reduces tumour formation of lung
cancer cells in vivo. However, antisense strategies could affect
targets that might be relevant for tumour formation other than
37LBP/p40. Moreover, it cannot be excluded that the observed
reduced tumorigenicity might be dependent on some event
different from down-regulation of the 37LBP/p40 transcript
because the effects generated in this study was assessed by use of a
single clone. Therefore, the mechanism of reduced tumorigenicity
in association with down-regulation of 37LBP/p40 expression is
currently being explored using different cancer cells in addition
to T11.
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